Archive


Category: Biomarker Discovery

  • Character Biosciences Raises $18M to Expand Precision Medicine Platform for Diseases of Aging

    What You Should Know: – Character Biosciences (“Character”), a precision medicine platform for diseases of aging raises $18M in a new funding round led by Innovation Endeavors, alongside leading life sciences investors Section 32 and Catalio Capital Management. Formerly known as Clover Therapeutics, the company’s data-driven approach integrates genomics, deep phenotyping and machine learning for […]

  • Medidata, Labcorp Partner to Expand Decentralized Clinical Trials for Digital Biomarker Discovery

    What You Should Know: – Medidata, a Dassault Systèmes company, today announced a first-of-its-kind partnership with Labcorp using the Medidata Sensor Cloud to introduce a new model to advance the use of medical-grade sensors in clinical trials and accelerate biomarker discovery. – As part of the partnership, Medidata will receive and process medical-grade sensor data within drug, vaccine […]

  • Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors

    What You Should Know: – Clinical trials technology company Medidata has acquired the digital biomarker business of MC10. – MC10’s offerings will bring novel clinical analytics and biosensor capabilities to Medidata’s existing technology solutions, enhancing Medidata’s capabilities to integrate data from wearable sensors – including clinical grade metrics – in clinical trials. – With this […]

  • Paige Lands Additional $15M for AI-Native Digital Pathology Ecosystem

    What You Should Know: – Paige secures an additional $15M from Goldman Sachs for a total Series B funding round of $70M for its AI-native digital pathology ecosystem. – The company’s continued product portfolio of innovation in telepathology and digital diagnostics accelerated by further investment. Paige, an NYC-based leader in computational pathology transforming the diagnosis […]